- Home
- FTW vs RCKT Comparison
FTW vs RCKT Comparison
Compare FTW & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTW
- RCKT
- Stock Information
- Founded
- FTW N/A
- RCKT 1999
- Country
- FTW
- RCKT United States
- Employees
- FTW N/A
- RCKT N/A
- Industry
- FTW Oil & Gas Production
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- FTW Energy
- RCKT Health Care
- Exchange
- FTW Nasdaq
- RCKT Nasdaq
- Market Cap
- FTW 465.8M
- RCKT 384.1M
- IPO Year
- FTW 2024
- RCKT N/A
- Fundamental
- Price
- FTW $10.45
- RCKT $3.17
- Analyst Decision
- FTW
- RCKT Buy
- Analyst Count
- FTW 0
- RCKT 13
- Target Price
- FTW N/A
- RCKT $12.88
- AVG Volume (30 Days)
- FTW N/A
- RCKT 2.6M
- Earning Date
- FTW N/A
- RCKT 11-06-2025
- Dividend Yield
- FTW N/A
- RCKT N/A
- EPS Growth
- FTW N/A
- RCKT N/A
- EPS
- FTW N/A
- RCKT N/A
- Revenue
- FTW N/A
- RCKT N/A
- Revenue This Year
- FTW N/A
- RCKT N/A
- Revenue Next Year
- FTW N/A
- RCKT $3,582.16
- P/E Ratio
- FTW N/A
- RCKT N/A
- Revenue Growth
- FTW N/A
- RCKT N/A
- 52 Week Low
- FTW N/A
- RCKT $2.19
- 52 Week High
- FTW N/A
- RCKT $17.83
- Technical
- Relative Strength Index (RSI)
- FTW N/A
- RCKT 37.92
- Support Level
- FTW N/A
- RCKT $3.19
- Resistance Level
- FTW N/A
- RCKT $3.35
- Average True Range (ATR)
- FTW 0.00
- RCKT 0.21
- MACD
- FTW 0.00
- RCKT -0.10
- Stochastic Oscillator
- FTW 0.00
- RCKT 11.90
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.